Six cancer research centers in the US have received a total of $540 million from Ludwig Cancer Research.
The awards, Ludwig says, are to allow the centers to expand on their previous work mapping the genomic landscape of cancer, developing new treatments, and training new investigators.
The centers — at Harvard University, Johns Hopkins University, the Massachusetts Institute of Technology, Memorial Sloan-Kettering Cancer Center,
Stanford University, and the University of Chicago — will each receive $90 million.
According to the Wall Street Journal, Sloan-Kettering will be putting the funds toward its immunotherapy efforts, while GenomeWeb Daily News notes that the University of Chicago and MIT say they will be using the award to continue their respective work on metastasis.
“With independent, flexible, and long-range funding we can now take an idea based on the best scientific and medical insights, and pursue it further regardless of how long it may take or the size of the eventual patient population it may benefit,” George Demetri, the co-director of the Ludwig Center at Harvard said in a statement.